Beximco Pharmaceuticals PLC. (DSE:BXPHARMA)
Bangladesh · Delayed Price · Currency is BDT 150.00
-0.60 (-0.40%)
At close: Jul 6, 2026
DSE:BXPHARMA Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | 8,650 | 6,941 | 5,830 | 4,614 | 5,123 | 5,128 |
Depreciation & Amortization | 1,875 | 1,800 | 1,994 | 2,061 | 1,667 | 1,114 |
Other Amortization | 32.69 | 32.69 | - | - | - | - |
Loss (Gain) From Sale of Assets | -43.37 | -34.93 | -16.38 | -13.82 | -12.62 | -3.96 |
Asset Writedown & Restructuring Costs | 184.5 | 184.5 | - | - | - | - |
Other Operating Activities | 217 | 122.15 | 124.15 | 158.2 | 346.09 | 60.3 |
Change in Accounts Receivable | 690.05 | 172.26 | -181.71 | -442.8 | 352.25 | 431.61 |
Change in Inventory | -247.12 | -1,371 | -61.78 | -1,829 | -2,565 | -1,084 |
Change in Accounts Payable | -1,144 | -688.95 | 149.4 | 1,060 | -9.72 | 587.17 |
Change in Income Taxes | 488.76 | 38.03 | -92.37 | 323.65 | -156.05 | -63.38 |
Change in Other Net Operating Assets | -235.33 | 27.72 | 619.81 | 154.32 | 469.16 | -146.06 |
Operating Cash Flow | 10,468 | 7,223 | 8,364 | 6,085 | 5,214 | 6,023 |
Operating Cash Flow Growth | 74.86% | -13.65% | 37.46% | 16.70% | -13.43% | 8.67% |
Capital Expenditures | -3,225 | -2,781 | -1,994 | -2,411 | -2,815 | -2,521 |
Sale of Property, Plant & Equipment | 31.56 | 60.33 | 26.96 | 23.35 | 24.06 | 32.83 |
Cash Acquisitions | - | - | - | - | -4,767 | - |
Sale (Purchase) of Intangibles | -348.1 | -247.94 | -240.83 | -231.54 | -124.29 | -37.73 |
Investment in Securities | -50 | -700 | -200 | - | - | - |
Other Investing Activities | 1.26 | 0.97 | 1.14 | 1.93 | 2.02 | 0.94 |
Investing Cash Flow | -3,591 | -3,668 | -2,406 | -2,617 | -7,680 | -2,525 |
Short-Term Debt Issued | - | - | - | - | 1,508 | - |
Long-Term Debt Issued | - | - | - | - | 2,731 | - |
Total Debt Issued | -1,437 | - | - | - | 4,238 | - |
Short-Term Debt Repaid | - | -971.27 | -3,625 | -229.38 | - | -2,375 |
Long-Term Debt Repaid | - | -152.52 | -1,049 | -1,763 | - | -504.64 |
Total Debt Repaid | -2,893 | -1,124 | -4,674 | -1,993 | - | -2,880 |
Net Debt Issued (Repaid) | -4,330 | -1,124 | -4,674 | -1,993 | 4,238 | -2,880 |
Common Dividends Paid | -211.55 | -1,603 | -1,586 | -1,568 | -1,623 | -578.35 |
Financing Cash Flow | -4,542 | -2,727 | -6,260 | -3,561 | 2,615 | -3,458 |
Foreign Exchange Rate Adjustments | 9.52 | 18.22 | 20.29 | 59.81 | 45.36 | - |
Net Cash Flow | 2,345 | 845.99 | -281.58 | -32.99 | 194.71 | 40.45 |
Free Cash Flow | 7,242 | 4,441 | 6,371 | 3,674 | 2,399 | 3,503 |
Free Cash Flow Growth | 130.26% | -30.29% | 73.40% | 53.15% | -31.51% | 6.17% |
Free Cash Flow Margin | 13.43% | 9.04% | 14.35% | 9.36% | 6.92% | 11.88% |
Free Cash Flow Per Share | 16.23 | 9.96 | 14.28 | 8.24 | 5.38 | 7.85 |
Cash Interest Paid | 739.24 | 976.73 | 1,149 | 1,272 | 1,002 | 861.45 |
Cash Income Tax Paid | 2,024 | 1,970 | 1,730 | 1,145 | 1,347 | 1,450 |
Levered Free Cash Flow | 4,172 | 2,310 | 4,311 | 1,909 | -1,004 | 1,799 |
Unlevered Free Cash Flow | 4,598 | 2,912 | 5,011 | 2,685 | -425.73 | 2,303 |
Change in Working Capital | -447.16 | -1,822 | 433.35 | -734.17 | -1,909 | -274.95 |